Table of contents
Volume 95, Issue 9
Published online 31 October 2006 (1131-1308)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor |
Book Review
Minireviews
Targeting sphingosine-1-phosphate for cancer therapy FREE
R A Sabbadini
Br J Cancer 95: 1131-1135; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603400
Mathematical models of targeted cancer therapy FREE
L H Abbott and F Michor
Br J Cancer 95: 1136-1141; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603310
Clinical Studies
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer FREE
N Takigawa, K Kiura, Y Segawa, Y Watanabe, H Kamei, T Moritaka, T Shibayama, H Ueoka, K Gemba, T Yonei, M Tabata, T Shinkai, S Hiraki, M Takemoto, S Kanazawa, K Matsuo and M Tanimoto for the Okayama Lung Cancer Study Group
Br J Cancer 95: 1142-1144; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603422
The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours FREE
T Powles, A Young, A Sammit, J Stebbing, D Short, M Bower, P M Savage, M J Seckl and P Schmid
Br J Cancer 95: 1145-1147; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603416
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas FREE
I Duran, J Kortmansky, D Singh, H Hirte, W Kocha, G Goss, L Le, A Oza, T Nicklee, J Ho, D Birle, G R Pond, D Arboine, J Dancey, S Aviel-Ronen, M-S Tsao, D Hedley and L L Siu
Br J Cancer 95: 1148-1154; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603419
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) FREE
A A Brandes, A Tosoni, G Cavallo, R Bertorelle, V Gioia, E Franceschi, M Biscuola, V Blatt, L Crinò and M Ermani
Br J Cancer 95: 1155-1160; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603376
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy FREE
M Campone, H Cortes-Funes, D Vorobiof, M Martin, C F Slabber, E Ciruelos, E Bourbouloux, C Mendiola, F M Delgado, C Colin, V Aslanis and P Fumoleau
Br J Cancer 95: 1161-1166; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603347
Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial FREE
T Klatte, A Ittenson, F-W Röhl, M Ecke, E P Allhoff and M Böhm
Br J Cancer 95: 1167-1173; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603391
18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response FREE
C M Gillham, J A Lucey, M Keogan, G J Duffy, V Malik, A A Raouf, K O'Byrne, D Hollywood, C Muldoon and J V Reynolds
Br J Cancer 95: 1174-1179; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603412
The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands FREE
E P M van Vliet, M J C Eijkemans, E W Steyerberg, E J Kuipers, H W Tilanus, A van der Gaast and P D Siersema
Br J Cancer 95: 1180-1185; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603374
Long-term outcome among men with conservatively treated localised prostate cancer FREE
J Cuzick, G Fisher, M W Kattan, D Berney, T Oliver, C S Foster, H Møller, V Reuter, P Fearn, J Eastham and P Scardino on behalf of the Transatlantic Prostate Group
Br J Cancer 95: 1186-1194; doi:10.1038/sj.bjc.6603411
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer FREE
S Eggington, P Tappenden, A Pandor, S Paisley, M Saunders, M Seymour, P Sutcliffe and J Chilcott
Br J Cancer 95: 1195-1201; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603348
Translational Therapeutics
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens FREE
J C Steele, E E Torr, K L Noakes, E Kalk, P A Moss, G M Reynolds, S G Hubscher, M van Lohuizen, D H Adams and L S Young
Br J Cancer 95: 1202-1211; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603369
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo FREE
J Theys, O Pennington, L Dubois, G Anlezark, T Vaughan, A Mengesha, W Landuyt, J Anné, P J Burke, P Dûrre, B G Wouters, N P Minton and P Lambin
Br J Cancer 95: 1212-1219; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603367
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells FREE
S A Byron, K B Horwitz, J K Richer, C A Lange, X Zhang and D Yee
Br J Cancer 95: 1220-1228; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603354
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor FREE
D Jamieson, A T Y Tung, R J Knox and A V Boddy
Br J Cancer 95: 1229-1233; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603414
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder FREE
M Hilmy, R Campbell, J M S Bartlett, A-M McNicol, M A Underwood and D C McMillan
Br J Cancer 95: 1234-1238; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603415
Molecular Diagnostics
The role of MYH and microsatellite instability in the development of sporadic colorectal cancer FREE
A Colebatch, M Hitchins, R Williams, A Meagher, N J Hawkins and R L Ward
Br J Cancer 95: 1239-1243; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603421
Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma FREE
R Maruyama, K Yamana, T Itoi, N Hara, V Bilim, T Nishiyama, K Takahashi and Y Tomita
Br J Cancer 95: 1244-1249; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603359
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer FREE
U Kailash, C C Soundararajan, R Lakshmy, R Arora, S Vivekanandhan and B C Das
Br J Cancer 95: 1250-1257; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603375
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei FREE
R Bibi, N Pranesh, M P Saunders, M S Wilson, S T O'Dwyer, P L Stern and A G Renehan
Br J Cancer 95: 1258-1264; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603398
Epidemiology
Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001) FREE
M Zorzi, D Puliti, M Vettorazzi, V De Lisi, F Falcini, M Federico, S Ferretti, I F Moffa, L Mangone, M P Mano, C Naldoni, A Ponti, A Traina, R Tumino and E Paci for the IMPACT Working Group
Br J Cancer 95: 1265-1268; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603405
Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong FREE
L A Tse, I T-S Yu, O W-K Mang and S-L Wong
Br J Cancer 95: 1269-1273; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603413
Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study FREE
A M Peters, C K Blair, M R Verneris, J P Neglia, L L Robison, L G Spector, G H Reaman, C A Felix and J A Ross
Br J Cancer 95: 1274-1276; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603388
Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden FREE
S C Larsson, E Giovannucci and A Wolk
Br J Cancer 95: 1277-1279; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603442
Lung cancer risk among German male uranium miners: a cohort study, 1946–1998 FREE
B Grosche, M Kreuzer, M Kreisheimer, M Schnelzer and A Tschense
Br J Cancer 95: 1280-1287; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603403
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives FREE
A Cassidy, J P Myles, S W Duffy, T Liloglou and J K Field
Br J Cancer 95: 1288-1290; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603386
Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study FREE
M Prochazka, P Hall, F Granath and K Czene
Br J Cancer 95: 1291-1295; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603404
Survival trends for small intestinal cancer in England and Wales, 1971–1990: national population-based study FREE
N Pashayan, C Lepage, B Rachet, L M Woods and M P Coleman
Br J Cancer 95: 1296-1300; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603417
Letters to the Editor
Study design and statistics in the epidemiology of breast cancer FREE
L Maraqa and M Lansdown
Br J Cancer 95: 1301; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603370
Reply: Study design and statistics in epidemiology of breast cancer FREE
M Garcia-Closas, L A Brinton, W F Anderson and M E Sherman
Br J Cancer 95: 1302-1303; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603371
Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastases from colorectal cancer? FREE
G Ferretti, A Alimonti and F Cognetti
Br J Cancer 95: 1304-1305; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603424
Reply: Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastasis from colorectal cancer FREE
E Goekkurt and J Stoehlmacher
Br J Cancer 95: 1306-1307; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603426
Book Review
Management of Thyroid Cancer and Related Nodular Disease FREE
A Cassoni
Br J Cancer 95: 1308; doi:10.1038/sj.bjc.6603397
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
